CHORD, NCT05788536: A Study of DB-OTO, an Adeno-associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations |
|
|
| Recruiting | 1/2 | 22 | Europe, US | DB-OTO | Regeneron Pharmaceuticals | Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) | 04/31 | 04/31 | | |